A new study published in the journal of BMC Gastroenterology showed that dementia risk was higher in patients with metabolic ...

SAN DIEGO -- A new blood test can predict the development of metabolic dysfunction-associated steatotic liver disease (MASLD) ...

Pregnant women with MASLD have over three times the risk of preterm birth, according to Swedish registry data. This risk ...

“If you have just been told you have MASLD, take a breath,” advised Tambini. “You are not alone, and you are not powerless. MASLD is very common, especially in people with conditions like obesity, ...

DelveInsight's analysis forecasts liver fibrosis market growth due to the introduction of emerging therapies, expecting an increase in market size during the study period (2020–2034). This anticipated ...

Discover a study presented at EASL 2025 that found that timely public health policies can reduce the global burden of MASLD.

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Bariatric surgery and GLP-1s conferred similar outcomes in mortality, adverse cardiovascular events and cirrhosis development ...

Pregnant women with metabolic dysfunction-associated steatotic liver disease (MASLD) have an increased risk of giving birth prematurely and the risk increase cannot be explained by obesity, according ...

Metabolic dysfunction-associated steatotic liver disease (MASLD), is the most common form of chronic liver disease worldwide.

Efficacy outcomes with subcutaneous infliximab (Zymfentra) for ulcerative colitis or Crohn's disease were largely comparable ...